22 Mar, 2024 Merger Control – European Commission’s power to review transactions under Article 22 at risk By Joost Haans In the much reported Illumina / Grail case, the European Commission (“Commission”) relied on Article 22 of the EU Merger Regulation...
12 Mar, 2024 Life Sciences Regulation in the EU: Overview By Marco de Morpurgo Nicola Landolfi Nadia Feola Heidi Waem +1 more... Show less DLA Piper's Life Sciences Regulatory team, led by Marco de Morpurgo, recently produced a Q&A guide to life sciences regulation in the EU...
24 May, 2022 Raw material shortage and its impact on the pharma industry By Sonia de Kondserovsky Marion Abecassis Marion de Galembert The COVID-19 pandemic, followed by the Ukraine war, has led to an economic crisis that has resulted in supply difficulties and a sharp...
17 May, 2022 Digital Health Transformation: The new Brazilian law on digital drugs leaflets By Bruna Rocha Juliana Marcondes Victoria Cristofaro Yesterday morning (12), the Brazilian Federal Government approved Law n. 14,338/22, which results from a bill of the Chamber of Deputies...
18 Aug, 2023 Advancing Healthcare: Unveiling the potential Latin American and Caribbean Medicines Agency By Bruna Rocha Carolina Caiado Juliana Marcondes Victoria Cristofaro +1 more... Show less Currently it is widely known that the Latin American markets operate with their respective regulatory health bodies, varying from having...
05 Jun, 2023 2023 Global M&A Intelligence Report – Life Sciences Supplement By Victoria Rhodes Robert Newman The DLA Piper Life Sciences sector team is delighted to announce the launch of our new 2023 Global M&A Intelligence Report – Life...
20 Sep, 2023 Sex bias, racial bias and AI – An ESG issue for the life sciences and healthcare sectors By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Alex Horder Jordan Davis +2 more... Show less It is increasingly important for organisations wishing to be good corporate citizens to have robust policies in place surrounding the...
30 May, 2023 Innovation Industries: The hot topic in global life sciences merger control By Alexandra Kamerling Claus Wenzler 1. Overview Mergers and acquisitions in innovation industries, and in particular in the life sciences sector, have experienced increased...
19 Oct, 2022 EU Pharma & Medical Device Regulation 2023 By Marco de Morpurgo Nicola Landolfi Our EU Life Sciences Regulatory team led by Marco de Morpurgo and Nicola Landolfi have produced a guide on EU Pharma & Medical Device...
19 Jan, 2023 What is the projected – and much anticipated – key pillar for the health sector in Brazil in 2023? By Bruna Rocha Juliana Marcondes Victoria Cristofaro During the World Economic Forum 2023 in Davos, specialists discussing the topic of health unanimously indicated that “the past three...
23 Apr, 2020 Clinical trials during the COVID-19 pandemic: A global guide By Dr Kokularajah Paheenthararajah After weeks of intensive collaboration and inspiring contributions from more than 100 Life Sciences enthusiasts across five continents,...
06 Jun, 2022 The Brazilian Minister of Health approves the Ordinance regulating telehealth in Brazil By Bruna Rocha Juliana Marcondes Victoria Cristofaro Last Thursday (2 June, 2022), Marcelo Queiroga – president of the Brazilian Society of Cardiology and current Minister of Health –...
06 Dec, 2023 New bill establishing rules for clinical trials with humans and instituting the National Ethics System governing clinical research - Brazil By Bruna Rocha Juliana Marcondes Victoria Cristofaro Last Wednesday 29 November, the Chamber of Deputies approved Bill No. 7082/2017 (in Portuguese, “Projeto de Lei n° 7082/2017”), which...
18 Feb, 2022 A new chapter in France's CBD legal saga By Marion Abecassis Marion de Galembert In an expected order of 24 January 2022, the interim relief judge of the French Administrative Supreme Court (Conseil d’Etat – “CE”)...
08 Mar, 2022 UK: New guidance on processing personal data for research purposes By James Clark Experiencing a global pandemic has provided us with many examples of the importance of scientific research to our lives. Meanwhile, a...
17 May, 2021 Interactions with healthcare professionals – launch of the new DLA Piper interactive compliance site for pharmaceutical companies By Marco de Morpurgo Andrzej Balicki, Ph.D. Ethical relations with healthcare professionals are of vital importance for pharmaceutical companies. Cooperation with them results in a...